{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:13:07Z","timestamp":1773403987953,"version":"3.50.1"},"reference-count":46,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.3892\/or.2013.2791","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T17:41:38Z","timestamp":1381426898000},"page":"2887-2896","source":"Crossref","is-referenced-by-count":21,"title":["Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness"],"prefix":"10.3892","volume":"30","author":[{"given":"FEDERICA","family":"RUFFINI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUCIO","family":"TENTORI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNALISA SUSANNA","family":"DORIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DIEGO","family":"ARCELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIULIA","family":"D\u2019AMATI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEFANIA","family":"D\u2019ATRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GRAZIA","family":"GRAZIANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEDRO MIGUEL","family":"LACAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"key20180107224025_b1-or-30-06-2887","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.det.2008.12.002","article-title":"Melanoma epidemiology and public health","volume":"27","author":"Berwick","year":"2009","journal-title":"Dermatol Clin"},{"key":"key20180107224025_b2-or-30-06-2887","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1158\/0008-5472.CAN-06-0921","article-title":"Markers and tissue resources for melanoma: meeting report","volume":"66","author":"Becker","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107224025_b3-or-30-06-2887","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0560.2010.01505.x","article-title":"Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study","volume":"37","author":"Nazarian","year":"2010","journal-title":"J Cutan Pathol"},{"key":"key20180107224025_b4-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1747.2000.00199.x","article-title":"Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor","volume":"115","author":"Lacal","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key20180107224025_b5-or-30-06-2887","first-page":"1625","article-title":"An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells","volume":"27","author":"Lacal","year":"2005","journal-title":"Int J Oncol"},{"key":"key20180107224025_b6-or-30-06-2887","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/cncr.11583","article-title":"Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases","volume":"98","author":"Schietroma","year":"2003","journal-title":"Cancer"},{"key":"key20180107224025_b7-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2010.10200.x","article-title":"Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression","volume":"164","author":"Ruffini","year":"2011","journal-title":"Br J Dermatol"},{"key":"key20180107224025_b8-or-30-06-2887","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1021\/jm990345w","article-title":"Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors","volume":"42","author":"Hennequin","year":"1999","journal-title":"J Med Chem"},{"key":"key20180107224025_b9-or-30-06-2887","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/14756369009035837","article-title":"Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins","volume":"3","author":"Sasaki","year":"1990","journal-title":"J Enzyme Inhib"},{"key":"key20180107224025_b10-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejca.2008.06.032","article-title":"Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide","volume":"44","author":"Lacal","year":"2008","journal-title":"Eur J Cancer"},{"key":"key20180107224025_b11-or-30-06-2887","first-page":"861","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells","volume":"34","author":"Lacal","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180107224025_b12-or-30-06-2887","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ijo.2013.1948","article-title":"Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2 dependent and independent mechanisms","volume":"43","author":"Ruffini","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107224025_b13-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI6870","article-title":"Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention","volume":"103","author":"Stetler-Stevenson","year":"1999","journal-title":"J Clin Invest"},{"key":"key20180107224025_b14-or-30-06-2887","doi-asserted-by":"crossref","first-page":"26411","DOI":"10.1074\/jbc.M001270200","article-title":"TIMP-2 is required for efficient activation of proMMP-2 in vivo","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107224025_b15-or-30-06-2887","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1755-148X.2008.00505.x","article-title":"Novel MITF targets identified using a two-step DNA microarray strategy","volume":"21","author":"Hoek","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180107224025_b16-or-30-06-2887","doi-asserted-by":"crossref","first-page":"26856","DOI":"10.1074\/jbc.M503388200","article-title":"Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator","volume":"280","author":"Fredriksson","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107224025_b17-or-30-06-2887","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/35010579","article-title":"PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor","volume":"2","author":"Li","year":"2000","journal-title":"Nat Cell Biol"},{"key":"key20180107224025_b18-or-30-06-2887","doi-asserted-by":"crossref","first-page":"27406","DOI":"10.1074\/jbc.M101056200","article-title":"Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor","volume":"276","author":"Gilbertson","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107224025_b19-or-30-06-2887","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1038\/sj.emboj.7600397","article-title":"Tissue plasminogen activator is a potent activator of PDGF-CC","volume":"23","author":"Fredriksson","year":"2004","journal-title":"EMBO J"},{"key":"key20180107224025_b20-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1096\/fj.02-0319com","article-title":"Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-\u03b1\u03b1 and -\u03b1\u03b2 receptors","volume":"16","author":"Cao","year":"2002","journal-title":"FASEB J"},{"key":"key20180107224025_b21-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMcibr050670","article-title":"Platelet-derived growth factor CC - a clinically useful angiogenic factor at last?","volume":"352","author":"Dimmeler","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107224025_b22-or-30-06-2887","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1172\/JCI19189","article-title":"Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180107224025_b23-or-30-06-2887","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/0008-5472.CAN-08-2724","article-title":"Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer associated fibroblasts","volume":"69","author":"Anderberg","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107224025_b24-or-30-06-2887","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/BJ20111020","article-title":"Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression","volume":"441","author":"Hurst","year":"2012","journal-title":"Biochem J"},{"key":"key20180107224025_b25-or-30-06-2887","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.onc.1204133","article-title":"PDGF-C is an EWS\/FLI induced transforming growth factor in Ewing family tumors","volume":"20","author":"Zwerner","year":"2001","journal-title":"Oncogene"},{"key":"key20180107224025_b26-or-30-06-2887","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1038\/sj.onc.1205486","article-title":"Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines","volume":"21","author":"Zwerner","year":"2002","journal-title":"Oncogene"},{"key":"key20180107224025_b27-or-30-06-2887","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0006-291X(02)00917-8","article-title":"Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells","volume":"296","author":"Andrae","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107224025_b28-or-30-06-2887","first-page":"3729","article-title":"Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumours","volume":"62","author":"Lokker","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107224025_b29-or-30-06-2887","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.24704","article-title":"Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma","volume":"126","author":"Yamano","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107224025_b30-or-30-06-2887","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","article-title":"PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment","volume":"15","author":"Crawford","year":"2009","journal-title":"Cancer Cell"},{"key":"key20180107224025_b31-or-30-06-2887","doi-asserted-by":"crossref","first-page":"309","DOI":"10.18632\/oncotarget.141","article-title":"VEGF-independent angiogenic pathways induced by PDGF-C","volume":"1","author":"Li","year":"2010","journal-title":"Oncotarget"},{"key":"key20180107224025_b32-or-30-06-2887","doi-asserted-by":"crossref","first-page":"e5123","DOI":"10.1371\/journal.pone.0005123","article-title":"PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment","volume":"4","author":"di Tomaso","year":"2009","journal-title":"PLoS One"},{"key":"key20180107224025_b33-or-30-06-2887","doi-asserted-by":"crossref","first-page":"22986","DOI":"10.1074\/jbc.M110.126946","article-title":"Skeletal muscle-specific calpain is an intracellular Na+-dependent protease","volume":"285","author":"Ono","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107224025_b34-or-30-06-2887","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrc3050","article-title":"The calpain system and cancer","volume":"11","author":"Storr","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107224025_b35-or-30-06-2887","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/carcin\/bgp098","article-title":"Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions","volume":"30","author":"Moretti","year":"2009","journal-title":"Carcinogenesis"},{"key":"key20180107224025_b36-or-30-06-2887","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Hodgkinson","year":"1993","journal-title":"Cell"},{"key":"key20180107224025_b37-or-30-06-2887","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1046\/j.0022-202x.2001.01563.x","article-title":"Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor","volume":"117","author":"Vachtenheim","year":"2001","journal-title":"J Invest Dermatol"},{"key":"key20180107224025_b38-or-30-06-2887","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(02)00762-6","article-title":"Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability","volume":"109","author":"McGill","year":"2002","journal-title":"Cell"},{"key":"key20180107224025_b39-or-30-06-2887","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2004.10.014","article-title":"Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF","volume":"6","author":"Du","year":"2004","journal-title":"Cancer Cell"},{"key":"key20180107224025_b40-or-30-06-2887","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev.genet.38.072902.092717","article-title":"Melanocytes and the microphthalmia transcription factor network","volume":"38","author":"Steingrimsson","year":"2004","journal-title":"Annu Rev Genet"},{"key":"key20180107224025_b41-or-30-06-2887","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03269","article-title":"Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression","volume":"433","author":"Carreira","year":"2005","journal-title":"Nature"},{"key":"key20180107224025_b42-or-30-06-2887","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200410115","article-title":"MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A","volume":"168","author":"Loercher","year":"2005","journal-title":"J Cell Biol"},{"key":"key20180107224025_b43-or-30-06-2887","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med"},{"key":"key20180107224025_b44-or-30-06-2887","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.14.3.301","article-title":"c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi","volume":"14","author":"Wu","year":"2000","journal-title":"Genes Dev"},{"key":"key20180107224025_b45-or-30-06-2887","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1128\/MCB.23.24.9073-9080.2003","article-title":"Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3","volume":"23","author":"Levy","year":"2003","journal-title":"Mol Cell Biol"},{"key":"key20180107224025_b46-or-30-06-2887","doi-asserted-by":"crossref","first-page":"e11940","DOI":"10.1371\/journal.pone.0011940","article-title":"Calpain 3 is a rapid-action, unidirectional proteolytic switch central to muscle remodelling","volume":"5","author":"De Morr\u00e9e","year":"2010","journal-title":"PLoS One"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2791\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T18:23:56Z","timestamp":1646763836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,10,10]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.3892\/or.2013.2791"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2791","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}